25620 Federal Register / Vol. 79, No. 86 / Monday, May 5, 2014 / Notices 

1Note that ‘‘marihuana’’ is the spelling originally 

used in the Controlled Substances Act (CSA). This 

document uses the spelling that is more common 

in current usage, ‘‘marijuana.’’ 

applications for a particular OVW grant 

program. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: An estimated 200 individuals 

participate in the OVW Peer Reviewer 

Database. 

6. An estimate of the total public 

burden (in hours) associated with the 

collection: The estimated public burden 

associated with this collection is 15 

minutes. It is estimated that respondents 

will take less than 15 minutes to 

complete periodic and infrequent 

submissions and updates to the 

database. The burden hours for 

collecting respondent data is 50 hours 

(200 respondents × .25 hours = 50 

hours). 

If additional information is required 

contact: Jerri Murray, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE., 3E.405B, 

Washington, DC 20530. 

Dated: April 29, 2014. 

Jerri Murray, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2014–10125 Filed 5–2–14; 8:45 am] 

BILLING CODE 4410–FX–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–378] 

Controlled Substances: Adjustment to 

the Established 2014 Aggregate 

Production Quota for Marijuana 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: Notice with request for 

comments. 

SUMMARY: This notice adjusts the 

established 2014 aggregate production 

quota for marijuana, a schedule I 

controlled substance under the 

Controlled Substances Act. 

DATES: Effective date: May 5, 2014. 

Comment date: Interested persons may 

file written comments on this notice in 

accordance with 21 CFR 1303.13. 

Electronic comments must be submitted 

and written comments must be 

postmarked, on or before June 4, 2014. 

Commenters should be aware that the 

electronic Federal Docket Management 

System will not accept comments after 

midnight Eastern Time on the last day 

of the comment period. 

ADDRESSES: To ensure proper handling 

of comments, please reference ‘‘Docket 

No. DEA–378’’ on all electronic and 

written correspondence. The DEA 

encourages that all comments be 

submitted electronically through the 

Federal eRulemaking Portal which 

provides the ability to type short 

comments directly into the comment 

field on the Web page or attach a file for 

lengthier comments. Please go to http:// 

www.regulations.gov and follow the 

online instructions at that site for 

submitting comments. Paper comments 

that duplicate electronic submissions 

are not necessary. Should you, however, 

wish to submit written comments, in 

lieu of electronic comments, they 

should be sent via regular or express 

mail to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

FOR FURTHER INFORMATION CONTACT: 

Ruth A. Carter, Office of Diversion 

Control, Drug Enforcement 

Administration; Mailing Address: 8701 

Morrissette Drive, Springfield, Virginia 

22152, Telephone: (202) 598–6812. 

SUPPLEMENTARY INFORMATION: 

Posting of Public Comments 

Please note that all comments 

received in response to this docket are 

considered part of the public record and 

will be made available for public 

inspection online at http://

www.regulations.gov. Such information 

includes personal identifying 

information (such as your name, 

address, etc.) voluntarily submitted by 

the commenter. 

The Freedom of Information Act 

(FOIA) applies to all comments 

received. If you want to submit personal 

identifying information (such as your 

name, address, etc.) as part of your 

comment, but do not want it to be made 

publicly available, you must include the 

phrase ‘‘PERSONAL IDENTIFYING 

INFORMATION’’ in the first paragraph 

of your comment. You must also place 

all of the personal identifying 

information you do not want made 

publicly available in the first paragraph 

of your comment and identify what 

information you want redacted. If you 

want to submit confidential business 

information as part of your comment, 

but do not want it to be made publicly 

available, you must include the phrase 

‘‘CONFIDENTIAL BUSINESS 

INFORMATION’’ in the first paragraph 

of your comment. You must also 

prominently identify the confidential 

business information to be redacted 

within the comment. If a comment has 

so much confidential business 

information that it cannot be effectively 

redacted, all or part of that comment 

may not be made publicly available. 

Comments containing personal 

identifying information or confidential 

business information identified as 

directed above will be made publicly 

available in redacted form. 

An electronic copy of this document 

is available at http://

www.regulations.gov for easy reference. 

If you wish to personally inspect the 

comments and materials received or the 

supporting information the DEA used in 

preparing this action, these materials 

will be available for public inspection 

by appointment. To arrange a viewing, 

please see the FOR FURTHER INFORMATION

CONTACT paragraph above. 

Pursuant to 21 CFR 1303.13, any 

interested person may submit written 

comments on or objections to this 

notice. Based on comments received in 

response to this notice, the 

Administrator may hold a public 

hearing on one or more issues raised in 

the comments and objections filed. In 

the event the Administrator decides to 

hold such a hearing, the Administrator 

shall publish notice of the hearing in the 

Federal Register. After consideration of 

any comments or objections, or after a 

hearing, if one is held, the 

Administrator shall issue and publish in 

the Federal Register a notice regarding 

the adjustment to the established 2014 

aggregate production quota for 

marijuana.1

Legal Authority 

The Drug Enforcement 

Administration (DEA) implements and 

enforces titles II and III of the 

Comprehensive Drug Abuse Prevention 

and Control Act of 1970, as amended. 

Titles II and III are referred to as the 

‘‘Controlled Substances Act’’ and the 

‘‘Controlled Substances Import and 

Export Act,’’ respectively, and are 

collectively referred to as the 

‘‘Controlled Substances Act’’ or the 

‘‘CSA’’ for the purpose of this action. 21 

U.S.C. 801–971. The DEA publishes the 

implementing regulations for these 

statutes in title 21 of the Code of Federal 

Regulations (CFR), parts 1300 to 1321. 

The CSA and its implementing 

regulations are designed to prevent, 

detect, and eliminate the diversion of 

controlled substances and listed 

chemicals into the illicit market while 

providing for the legitimate medical, 

scientific, research, and industrial needs 

of the United States. Controlled 

substances have the potential for abuse 


emcdonald on DSK67QTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 86 / Monday, May 5, 2014 / Notices 25621 

and dependence and are controlled to 

protect the public health and safety. 

Section 306 of the CSA (21 U.S.C. 

826) requires the Attorney General to 

establish aggregate production quotas 

for each basic class of controlled 

substance listed in schedules I and II 

each year. The Attorney General has 

delegated this authority under 21 U.S.C. 

826 to the Administrator of the DEA, 28 

CFR 0.100. 

Background 

The DEA established the initial 2014 

aggregate production quotas and 

assessments for annual need on 

September 9, 2013 (78 FR 55099). The 

notice stipulated that, as provided for in 

21 CFR 1303.13, all aggregate 

production quotas and assessments for 

annual need are subject to adjustment. 

Analysis for Adjusting the Established 

2014 Aggregate Production Quota for 

Marijuana Effective on the Date of 

Publication 

In determining to adjust the aggregate 

production quota, the DEA takes into 

consideration, among other factors, the 

relevant scientific and research needs of 

the United States. 21 U.S.C. 826; 21 CFR 

1303.13(b)(5). 

The National Institute on Drug Abuse 

(NIDA) is a component of the National 

Institutes of Health and the U.S. 

Department of Health and Human 

Services, and it oversees the cultivation, 

production and distribution of researchgrade marijuana on behalf of the United 

States Government, pursuant to the 

Single Convention on Narcotic Drugs 

(March 30, 1961, 18 UST 1407). NIDA 

recently notified the DEA that it 

required additional supplies of 

marijuana to be manufactured in 2014 to 

provide for current and anticipated 

research efforts involving marijuana. 

Specifically, NIDA stated that 600 

kilograms is necessary to be 

manufactured in 2014. 

The DEA was unaware of NIDA’s 

additional need at the time the initial 

aggregate production quota for 

marijuana was established in September 

2013. 

The aggregate production quota for 

marijuana should be increased in order 

to provide a continuous and 

uninterrupted supply of marijuana in 

support of DEA-registered researchers 

who are approved by the Federal 

Government to utilize marijuana in their 

research protocols. 

In the event the established aggregate 

production quota is increased, DEA 

regulations require general notice of the 

adjustment prior to adjusting the quota. 

21 CFR 1303.13(c). Due to the 

manufacturing process unique to 

marijuana, including the length of time 

and conditions necessary to propagate 

and process the substance for 

distribution in 2014, it is necessary to 

adjust the initial, established 2014 

aggregate production quota for 

marijuana as soon as practicable. 

Accordingly, the Administrator finds 

good cause to adjust the aggregate 

production quota for marijuana before 

accepting written comments from 

interested persons or holding a public 

hearing, pursuant to 21 CFR 1303.13(c). 

More specifically, the Administrator 

finds, based on NIDA’s aforementioned 

submission to DEA, that it is in the 

public interest to adjust the aggregate 

production quota immediately to ensure 

that the cultivation of marijuana to meet 

NIDA’s anticipated needs to supply 

researchers can proceed within the 

current grow cycle. For this same 

reason, the Administrator finds that 

delaying the adjustment to the aggregate 

production quota for marijuana until 

after the comment period would be 

impracticable. Any such comments 

shall be considered if submitted in 

accordance with the procedures 

described herein. 

In issuing this adjustment, the DEA 

has taken into account the criteria that 

the DEA is required to consider in 

accordance with 21 CFR 1303.13(b). The 

DEA determines whether to adjust the 

aggregate production quotas for basic 

classes of schedule I and II controlled 

substances by considering: (1) Changes 

in demand for the basic class, changes 

in the national rate of net disposal for 

the class, and changes in the rate of net 

disposal by the registrants holding 

individual manufacturing quotas for the 

class; (2) whether any increased demand 

or changes in the national or individual 

rates of net disposal are temporary, 

short term, or long term; (3) whether any 

increased demand can be met through 

existing inventories, increased 

individual manufacturing quotas, or 

increased importation, without 

increasing the aggregate production 

quota; (4) whether any decreased 

demand will result in excessive 

inventory accumulation by all persons 

registered to handle the class; and (5) 

other factors affecting the medical, 

scientific, research, and industrial needs 

of the United States and lawful export 

requirements, as the Administrator finds 

relevant. 

Based on the above, the Administrator 

adjusts the established 2014 aggregate 

production quota for marijuana, to be 

manufactured in the United States in 

2014 to provide for the estimated 

scientific, research, and industrial needs 

of the United States, and the 

establishment and maintenance of 

reserve stocks, expressed in grams of 

anhydrous acid or base, as follows: 

Basic class— 

schedule I 

Previously 

established 

2014 quota 

(g) 

Adjusted 

2014 Quota 

(g) 

Marijuana .......... 21,000 650,000 

Dated: April 29, 2014. 

Michele M. Leonhart, 

Administrator. 

[FR Doc. 2014–10202 Filed 5–2–14; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Comment Request for Information 

Collection for Form ETA–9089, 

Application for Permanent 

Employment Certification (OMB 

Control Number 1205–0451), Extension 

of Currently Approved Collection 

AGENCY: Employment and Training 

Administration (ETA), Labor. 

ACTION: Notice. 

SUMMARY: The Department of Labor 

(DOL), as part of its continuing effort to 

reduce paperwork and respondent 

burden, conducts a preclearance 

consultation program to provide the 

public and Federal agencies with an 

opportunity to comment on proposed 

and/or continuing collections of 

information in accordance with the 

Paperwork Reduction Act of 1995 (44 

U.S.C. 3506(c)(2)(A)). This program 

helps ensure that requested data can be 

provided in the desired format, 

reporting burden (time and financial 

resources) is minimized, collection 

instruments are clearly understood, and 

the impact of collection requirements on 

respondents can be properly assessed. 

Currently, ETA is soliciting comments 

concerning the collection of data about 

Form ETA–9089, Application for 

Permanent Employment Certification 

(OMB Control Number 1205–0451), 

which expires August 31, 2014. The 

form is used in DOL’s employmentbased immigration program by 

employers to request permission to 

bring foreign workers to the United 

States as immigrants, and in the 

Department of Homeland Security’s 

National Interest Waiver (NIW) program 

by individuals applying for a waiver of 

the job offer requirement if the waiver 

is deemed to be in the national interest. 

DATES: Written comments must be 

submitted to the office listed in the 


emcdonald on DSK67QTVN1PROD with NOTICES